|Articles|May 1, 2016
- BioPharm International-05-01-2016
- Volume 29
- Issue 5
Ultracentrifuge Allows for Multi-Wavelength Analysis
Listen
0:00 / 0:00
Key Takeaways
- The Optima AUC ultracentrifuge determines molecular weight, size, shape, and polydispersity with advanced features for comprehensive analysis.
- A 15-inch touch-screen and remote data export capabilities enhance user interaction and data management.
The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity.
Advertisement
The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity. The Optima AUC has a 38.1-cm (15-inch diagonal) touch-screen with the ability to export data locally or remotely. The optics are contained outside the rotor chamber, reducing the impact of the g-force on the optics. The Optima AUC also allows molecules to float free and unbound so that researchers are able to characterize them in their native state. The ultracentrifuge can perform multi-wavelength analysis and allows for the development of new detection systems.
Articles in this issue
over 9 years ago
Using Single-Use Systems in Aseptic Fill-Finishover 9 years ago
Filling and Closing System Reduces Decontamination Cycleover 9 years ago
Outsourcing of Biomanufacturing in 2016over 9 years ago
Reporting Quality Metrics to FDAover 9 years ago
The Value of Saving Livesover 9 years ago
Realizing the Potential of CAR-T Cell Therapiesover 9 years ago
Advancing cell therapy safetyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
5
